Nonrisk-adapted Sequential Intravesical Gemcitabine and Docetaxel for Nonmuscle-invasive Bladder Cancer: The Time Is Now

J Urol. 2023 Jul;210(1):5-7. doi: 10.1097/JU.0000000000003438. Epub 2023 Mar 31.
No abstract available

Keywords: administration; docetaxel; gemcitabine; intravesical; non-muscle invasive bladder neoplasms.

Publication types

  • Editorial

MeSH terms

  • Administration, Intravesical
  • BCG Vaccine / therapeutic use
  • Deoxycytidine
  • Docetaxel / therapeutic use
  • Gemcitabine*
  • Humans
  • Neoplasm Invasiveness
  • Urinary Bladder Neoplasms* / drug therapy

Substances

  • Gemcitabine
  • Docetaxel
  • Deoxycytidine
  • BCG Vaccine